Related Experiment Video
Updated: Jul 3, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Global characterization of RNA editing in genetic regulation of multiple ovarian cancer subtypes
Yulan Wang1, Jing Wu2, Jian Zhao1
1Department of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China.
Abstract:
RNA editing plays an extensive role in the initiation and progression of cancer. However, the overall profile and molecular functions of RNA editing in different ovarian cancer subtypes have not been fully characterized and elucidated. Here, we conducted a study on RNA editing in four cohorts of ovarian cancer subtypes through large-scale parallel reporting and bioinformatics analysis. Our findings revealed that RNA editing patterns exhibit subtype-specific characteristics within cancer subtypes. The expression pattern of ADAR and the number of differential editing sites varied under different conditions. CCOC and EOC exhibited significant editing deficiency, whereas HGSC and MOC displayed significant editing excess. The sites within the turquoise module of the coedited network also revealed their correlation with ovarian cancer. In addition, we identified an average of over 40,000 cis-edQTLs in the four subtypes. Finally, we explored the association between RNA editing and drug response, uncovering several potentially effective editing-drug pairs (EDP) and suggesting the conceivable utility of RNA editing sites as therapeutic targets for cancer treatment. Overall, our comprehensive study has identified and characterized RNA editing events in various subtypes of ovarian cancer, providing a new perspective for ovarian cancer research and facilitating the development of medical interventions and treatments.
Insights
RNA editing patterns differ across ovarian cancer subtypes, with some showing deficiency and others excess. These findings offer new therapeutic targets for ovarian cancer treatment.
Area of Science:
- Biochemistry
- Genomics
- Oncology
Background:
- RNA editing is crucial in cancer development.
- Ovarian cancer subtypes have not been fully characterized regarding RNA editing.
- Understanding RNA editing profiles is key for targeted therapies.
Purpose of the Study:
- To characterize RNA editing patterns and molecular functions in different ovarian cancer subtypes.
- To investigate the relationship between RNA editing and drug response.
- To identify potential therapeutic targets for ovarian cancer.
Main Methods:
- Large-scale parallel reporting and bioinformatics analysis of four ovarian cancer cohorts.
- Analysis of ADAR expression and differential editing sites.
- Identification of cis-editing quantitative trait loci (cis-edQTLs).
Main Results:
- RNA editing patterns are subtype-specific in ovarian cancer.
- CCOC and EOC showed editing deficiency; HGSC and MOC showed editing excess.
- Identified over 40,000 cis-edQTLs and potential editing-drug pairs (EDPs).
Conclusions:
- RNA editing profiles vary significantly across ovarian cancer subtypes.
- RNA editing sites represent potential therapeutic targets for ovarian cancer.
- This study provides novel insights into ovarian cancer mechanisms and treatment strategies.
Related Concept Videos
RNA Editing
Regulation of Expression at Multiple Steps
MicroRNAs
RNA Splicing
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

